Veterinary Medicines

ORIDERMYL POMMADE AURICULAIRE

Authorised
  • NEOMYCIN SULFATE
  • Permethrin
  • Triamcinolone acetonide
  • Nystatin
Download as PDF

Product identification

Medicine name:
ORIDERMYL POMMADE AURICULAIRE
Active substance:
  • NEOMYCIN SULFATE
  • Permethrin
  • Triamcinolone acetonide
  • Nystatin
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    3500.00
    international unit(s)
    /
    1.00
    gram(s)
  • Permethrin
    10.00
    milligram(s)
    /
    1.00
    gram(s)
  • Triamcinolone acetonide
    0.10
    gram(s)
    /
    1.00
    gram(s)
  • Nystatin
    100000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Ear ointment
Withdrawal period by route of administration:
  • Auricular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC04
  • QS02CA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1501980 8/2008
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/01/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/01/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."